The Department of Veterans Affairs (VA) is launching an ambitious program offering drug treatment to veterans infected with the hepatitis C virus (HCV). Nearly 4 million Americans are estimated to be infected with the virus; a disproportionate number of them are veterans of the Vietnam era, many of whom had blood transfusions before 1992, when HCV screening of donated blood began.
"Hepatitis C is of particular concern for VA because of its greater prevalence in VA's service population," said Kenneth W. Kizer, MD, MPH, VA under secretary for health.
Stephenson J. Hepatitis C Drugs for Veterans. JAMA. 1999;281(7):600. doi:10.1001/jama.281.7.600-JHA90000-3-1